ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Epigenetics"

  • Abstract Number: 2556 • 2016 ACR/ARHP Annual Meeting

    Deficient Expression of the Novel Rheumatoid Arthritis (RA) Risk Gene, LBH, Induces S Phase Arrest in RA Fibroblast-like Synoviocytes (FLS)

    Shinji Matsuda1, Deepa Hammaker2, Steven Dowdy3, David L. Boyle4 and Gary Firestein5, 1Medicine, UC San Diego, La Jolla, CA, 2Division of Rheumatology, Allergy and Immunology, UCSD School of Medicine, La Jolla, CA, 3UC San Diego School of Medicine, La Jolla, CA, 4Division of Rheumatology, Allergy and Immunology, University of California, San Diego, La Jolla, CA, 5Medicine, UCSD, La Jolla, CA

    Background/Purpose:  LBH (Limb-bud and heart development) was recently identified as an RA risk gene that has abnormally methylated loci and a functional enhancer SNP in…
  • Abstract Number: 3119 • 2016 ACR/ARHP Annual Meeting

    Complete Whole Genome Transcriptome, DNA Methylation, and Histone Mark Analysis of Rheumatoid Arthritis (RA) Fibroblast-like Synoviocytes (FLS) Reveals a Distinctive Epigenetic Landscape and Critical Pathogenic Pathways

    Rizi Ai1, Deepa Hammaker2, David L. Boyle3, Andre ‎ Wildberg4, Keisuke Maeshima2, Emmanuele Palescandolo5, Vinod Krishna5, Bryan Linggi6, Radu Dobrin5, John W. Whitaker7, Wei Wang8 and Gary Firestein9, 1Chemistry and Biochemistry, UC San Diego, La Jolla, CA, 2Division of Rheumatology, Allergy and Immunology, UCSD School of Medicine, La Jolla, CA, 3Division of Rheumatology, Allergy and Immunology, University of California, San Diego, La Jolla, CA, 4Chemistry and Biochemistry, UNIVERSITY OF CALIFORNIA SAN DIEGO, LA JOLLA, CA, 5Janssen Pharmaceuticals, Spring House, PA, 6janssen Pharmaceuticals, Spring House, PA, 7Janssen Pharmaceuticals, La Jolla, CA, 8Chemistry and Biochemistry, University of California, San Diego, La Jolla, CA, 9Medicine, UCSD, La Jolla, CA

    Background/Purpose: RA FLS display a unique aggressive phenotype with a distinctive DNA methylation profile that marks genes involved with cytokine signaling, cell recruitment, and matrix…
  • Abstract Number: 3120 • 2016 ACR/ARHP Annual Meeting

    RA Net: A Systems Biology Approach to Identify Genes Regulating Pathogenic Pathways in Rheumatoid Arthritis (RA) Fibroblast-like Synoviocytes (FLS)

    Wei Wang1, RIchard Ainsworth2, Richard Stein2, Rizi Ai3 and Gary Firestein4, 1Chemistry and Biochemistry, University of California, San Diego, La Jolla, CA, 2UC San Diego, La Jolla, CA, 3Chemistry and Biochemistry, UC San Diego, La Jolla, CA, 4Medicine, UCSD, La Jolla, CA

    Background/Purpose: Rheumatoid arthritis (RA) remains a significant unmet need despite improved therapy. Defining the interlaced nature of gene regulation and disease pathogenesis using integrative systems…
  • Abstract Number: 3256 • 2015 ACR/ARHP Annual Meeting

    Epigenetic Chromosome Conformations Predict MTX Responsiveness in Early Rheumatoid Arthritis Patients

    Claudio Carini1, Aroul Ramadass2, Philip Jordan2, Ewan Hunter2, Alexandre Akoulitchev2, Iain. B. McInnes3, Carl. S. Goodyear3 and Scottish Early Rheumatoid Arthritis Inception Cohort Investigators, 135 Cambridgepark Drive, Pfizer, Cambridge, MA, 2Oxford Biodynamics, Oxford, United Kingdom, 3Institute of Infection, Immunity and Inflammation, College of Medicine, Veterinary Medicine and Life Sciences, University of Glasgow, Glasgow, United Kingdom

    Background/Purpose: In early rheumatoid arthritis (RA), it is not possible to predict response to first line DMARDs (e.g. methotrexate (MTX)) and as such treatment decisions…
  • Abstract Number: 95 • 2015 ACR/ARHP Annual Meeting

    Validation of Differential Methylation in Paternally Versus Maternally Transmitted Psoriatic Disease

    Remy Pollock1, Darren O'Reilly2, Amanda Dohey2, Dianne Codner2, Vinod Chandran3, Dafna Gladman3 and Proton Rahman4, 1University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 2Memorial University of Newfoundland, St. John's, NF, Canada, 3Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 4Computer Sciences, Memorial University of Newfoundland, St. John's, NF, Canada

    Background/Purpose: Several studies have demonstrated excessive paternal transmission of psoriasis and psoriatic arthritis (PsA). This phenomenon is thought to be mediated by genomic imprinting. We…
  • Abstract Number: 804 • 2015 ACR/ARHP Annual Meeting

    Prolactin Induces Interferon Regulatory Factor 1 Activation and Histone H4 Hyperacetylation in Primary Monocytes Comparable to Changes Seen in Monocytes from Systemic Lupus Erythematosus Patients

    Yiu Tak Leung1, Kathleen E. Sullivan2, Kelly Maurer3, Li Song4 and Lihua Shi3, 1Medicine/Rheumatology, University of Pennsylvania, Philadelphia, PA, 2Allergy Immunology, The Children's Hospital of Philadelphia, Philadelphia, PA, 3Immunology ARC 1216, The Children's Hospital of Philadelphia, Philadelphia, PA, 4Allergy Immunology, Children's Hospital of Philadelphia, Philadelphia, PA

    Background/Purpose: : Epigenetic changes have been described in systemic lupus erythematosus (SLE) and offer a potential explanation for the chronicity of disease. We previously found…
  • Abstract Number: 1130 • 2015 ACR/ARHP Annual Meeting

    Global DNA Methylation Analysis of Osteoarthritic Subchondral Bone Reveals Significant Regional Variation and Similarity to Overlying Cartilage

    Matlock A. Jeffries1,2, Madison Andrews3, Mary Beth Humphrey1, Judith A. James4 and Amr H. Sawalha5, 1Rheumatology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 2Arthritis and Clinical Immunology, Oklahoma Medical Research Association, Oklahoma City, OK, 3Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 4Arthritis & Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 5Univers, Oklahoma City, OK

    Background/Purpose: Osteoarthritis (OA) is a leading cause of chronic disability affecting a majority of individuals over age 70. Outside of cartilage, little is known regarding…
  • Abstract Number: 1163 • 2015 ACR/ARHP Annual Meeting

    Dynamic Regulation of Enhancers and Super-Enhancers in Rheumatoid Arthritis Synovial Finroblasts

    Sung-Ho Park1, Christopher Sohn1, Konstantinos Loupasakis2, Angela Lee3, Eugenia Giannopoulou1, Lionel B. Ivashkiv3 and George D. Kalliolias1, 1Hospital for Special Surgery, New York, NY, 2Rheumatology, Hospital for Special Surgery Weill Cornell Medical College, New York, NY, 3Medicine, Hospital for Special Surgery, New York, NY

    Background/Purpose: Enhancers are regulatory elements that modulate transcriptional rates of genes. Super-enhancers (SupE) are extremely large enhancers associated primarily with highly expressed genes that have…
  • Abstract Number: 1239 • 2015 ACR/ARHP Annual Meeting

    Significant Impact of Microrna-Target Gene Networks on the Genetics of Rheumatoid Arthritis

    Yukinori Okada1,2 and Toshihiro Tanaka3,4, 1Department of Human Genetics and Disease Diversity, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan, 2Laboratory for Statistical Analysis, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan, 3Bioresource Research Center, Department of Human Genetics and Disease Diversity, Tokyo Medical and Dental University, Tokyo, Japan, 4Laboratory for Cardiovascular Diseases, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan

    Background/Purpose: MicroRNA (miRNA), a short endogenous noncoding RNA, has a major role in the degradation and translational repression of a specific gene through its binding…
  • Abstract Number: 1242 • 2015 ACR/ARHP Annual Meeting

    Germ Line DNA Methylation Profiling Provides Novel Insights into the Parent-of-Origin Effect in Psoriatic Disease

    Remy Pollock1, Darren O'Reilly2, Proton Rahman3, Vinod Chandran4 and Dafna Gladman4, 1University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 2Memorial University of Newfoundland, St. John's, NF, Canada, 3Computer Sciences, Memorial University of Newfoundland, St. John's, NF, Canada, 4Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada

    Background/Purpose: Parent-of-origin effects refer to the differential risk or pathogenicity of a disease that depends on the sex of the disease-transmitting parent. Excessive paternal transmission…
  • Abstract Number: 1250 • 2015 ACR/ARHP Annual Meeting

    DNA Methylation and Its Relation to Immunological Phenotypes in Peripheral Blood: A Study of Anti-CCP Antibody Positivity from a Population-Based Pool

    Sasha Bernatsky1, Xiaojian Shao2, Marie-Michelle Simon2, Marvin J. Fritzler3, Philip Awadalla4,5, Marie Hudson6, Ines Colmegna7, Tony Kwan2 and Tomi Pastinen2, 1Divisions of Rheumatology and Clinical Epidemiology, McGill University Health Centre, Montreal, QC, Canada, 2Department of Human Genetics, McGill University and Génome Québec Innovation Centre, Montreal, QC, Canada, 3Medicine, University of Calgary, Calgary, AB, Canada, 4Medicine, Université de Montreal, Montreal, QC, Canada, 5Ontario Institute for Cancer Research, Toronto, ON, Canada, 6McGill University, Jewish General Hospital, Montreal, QC, Canada, 7Rheumatology, McGill University Health Centre, Montreal, QC, Canada

    Background/Purpose: DNA methylation represents an important potential mediator of environmental influences on autoimmunity, including rheumatoid arthritis (RA).  Genome-wide methylation in the context of clinical phenotypes…
  • Abstract Number: 1255 • 2015 ACR/ARHP Annual Meeting

    Genome-Wide DNA Methylation Patterns in CD4+ T Reveal Significant Contribution of DNA Methylation to Rheumatoid Arthritis

    Shicheng Guo1,2, Ting Jiang1,2, Rongsheng Wang1,2, Yi Shen1,2, Xiao Zhu3, Fengmin Bai1,2, Qin Ding1,2, Guangjie Chen4 and Dongyi He1,2, 1Department of Rheumatology, Shanghai Guanghua Hospital of Integrated Traditional and Western Medicine, Shanghai, China, 2Arthritis Institute of integrated Traditional and Western medicine, Shanghai Chinese Medicine Research Institute, Shanghai, China, 3Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, Guangdong Medical University, Guangzhou, China, 4Department of Immunology and Microbiology, Shanghai JiaoTong University School of Medicine, Shanghai, China

    Background/Purpose: Rheumatoid arthritis (RA) is an autoimmune disease that causes chronic inflammation of the joints. Recent evidence showed more and more importance of the epigenetic…
  • Abstract Number: 1624 • 2015 ACR/ARHP Annual Meeting

    Epigenetic Profiling of CD14+ and CD16+ Monocyte Subtypes in Rheumatoid Arthritis.  Alterations Related to Cardiovascular Disease and Endothelial Dysfunction

    Nuria Barbarroja1,2, Patricia Ruiz-Limon1, Carlos Perez-Sanchez1, Yolanda Jiménez Gómez1, MariCarmen Abalos-Aguilera1, Pedro Segui3, Pilar Font1, Ángeles Aguirre Zamorano1, Jerusalem Calvo-Gutierrez1, Rafaela Ortega1, M. Carmen Castro Villegas1, Eduardo Collantes-Estévez1, Alejandro Escudero-Contreras1 and Chary Lopez-Pedrera1, 1IMIBIC-Reina Sofia University Hospital, Rheumatology Unit, Cordoba, Spain, 2Rheumatology Unit, IMIBIC-Reina Sofia University Hospital, Cordoba, Spain, 3IMIBIC-Reina Sofia University Hospital, Radiology Unit, Cordoba, Spain

    Background/Purpose: Monocytes play a key role in the pathogenesis of the cardiovascular disease (CVD). Three monocyte subsets have been described based on their CD14 and…
  • Abstract Number: 1950 • 2015 ACR/ARHP Annual Meeting

    Methylation-Dependent Interference of Two Promoters for the Treg-Specific Protein, Garp, Contributes to Altered Treg Function in Rheumatoid Arthritis

    Viktoria Soentgerath1, Sonja Haupt2, Jan Leipe3, Hendrik Schulze-Koops1 and Alla Skapenko1, 1Division of Rheumatology and Clinical Immunology, University of Munich, Munich, Germany, 2Division of Rheumatology and Clinical Immunology, Med.Klinik und Poliklinik IV, University of Munich, Munich, Germany, 3Division of Rheumatology, University of Munich, Munich, Germany

    Background/Purpose: Recently, genome-wide studies identified several Treg-specific genes containing hypomethylated regions that are critical for their expression, so called Treg-specific demethylated regions (TSDR). For example,…
  • Abstract Number: 2573 • 2015 ACR/ARHP Annual Meeting

    Confirmatory Analysis of Methylome Signatures in Rheumatoid Arthritis Using an Independent Dataset

    Rizi Ai1, Deepa Hammaker2, Wei Wang3 and Gary S. Firestein4, 1University of California San Diego, La Jolla, CA, 2Division of Rheumatology, Allergy and Immunology, UCSD School of Medicine, La Jolla, CA, 3Chemistry and Biochemistry, University of California, San Diego, La Jolla, CA, 4Div of Rheumatology, UCSD School of Medicine, La Jolla, CA

    Background/Purpose: Epigenetics can contribute to the pathogenesis of rheumatoid arthritis (RA). A DNA methylation signature that distinguishes RA fibroblast-like synoviocytes (FLS) from osteoarthritis (OA) FLS…
  • « Previous Page
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • 13
  • …
  • 15
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology